Skip to main content
. 2020 Aug 10;17(16):5795. doi: 10.3390/ijerph17165795
A1C Average haemoglobin level over three months
CSII Continuous subcutaneous insulin infusion
CMax Maximal insulin concentration
DPI Dry powder inhaler
EDIC Epidemiology of diabetes interventions and complications
FDA Food and Drug Administration
HbA1c Average glycated haemoglobin level
ICU Intensive care unit
iDMS Insulin diabetes management system
IU Insulin unit
pMDI Pressurised metered dose inhalers
RD Respirable dose
SMI Soft mist inhaler
SVN Small-volume inhaler
T1DM Type-1 diabetes
T2DM Type-1 diabetes
TI Technosphere insulin
VMN Vibrating mesh nebuliser